Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1834 of 6351
-
Training healthcare teams to see the whole person behind the illness
Knowledge-focused CompletedWhen people become seriously ill, healthcare decisions are influenced not only by their medical condition, but also by their personal situation, values, wishes, and daily life circumstances. A medically appropriate treatment may not always fit what is important or realistic for a…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Clot-Busting drugs may cut death risk in lung clot patients
Disease control CompletedThe aim of investigators was to study the effect and safety of Thrombolysis in Intermediate high risk pulmonary embolism patients with low bleeding risk as regards Mortality and bleeding events.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill targets hormone imbalance from adrenal tumors
Disease control CompletedThis is study with SPI-62 to evaluate the efficacy, safety, and pharmacological effect of SPI-62 in subjects with hypercortisolism related to a benign adrenal tumor. Each subject will receive 2mg of SPI-62 daily.
Phase 2 • Sponsor: Sparrow Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Magic mushroom mystery: can psilocybin fight depression without the trip?
Knowledge-focused CompletedPsilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. In healthy volunteers, the psychedelic effects of psilocybin have been shown to be bl…
Phase 2 • Sponsor: Centre for Addiction and Mental Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can a simple timing change make leukemia therapy safer?
Disease control Recruiting nowChanging the schedule of intrathecal chemotherapy to be given before and during blinatumomab will maintain the anti-leukemic effects of this drug while at the same time adding the benefit of limiting the neurotoxicity associated with cytokine release.
Phase 2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New Real-World study tracks joint protection in hemophilia a patients
Disease control OngoingThis is a prospective, observational, multi-center longitudinal cohort study to describe the real-world effectiveness, safety and treatment usage of efanesoctocog alfa in patients with hemophilia A treated per standard of care in the US and Japan. Patients will be enrolled in th…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Church-based diabetes program aims to curb soaring rates in marshall islands
Disease control Recruiting nowHealth disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) …
Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Can a shot of interferon gamma help ventilated patients beat pneumonia faster?
Disease control Recruiting nowClinical presentation of patients after severe injury such as a severe infection, trauma or extensive burns is characterized by the simultaneous occurrence of dysregulation of the initial inflammatory response and immunosuppression associating quantitative and functional alterati…
Phase 3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy may slow severe nearsightedness in kids
Disease control CompletedPeripheral contact lens in controlling myopia progression in high myopia children(PAM)is a prospective, single-center, randomized controlled trial with three parallel arms conducted at Beijing Tongren Hospital. Chinese children aged 6-12 years with high myopia (spherical equivale…
Phase 4 • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New radiation approach aims to ease head and neck cancer pain in fewer sessions
Symptom relief Recruiting nowTo learn if it is effective to use advanced radiation treatment techniques (stereotactic radiation or "SBRT") to safely deliver a strong dose of radiation to your tumor in a shorter period of time than would typically be feasible with traditional methods.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New combo therapy aims to boost brain repair after stroke
Symptom relief CompletedIt is known that the acute period of stroke occurs is accompanied by oxidative stress, when intense generation of reactive oxygen species (ROS) have a toxic effect, which causes oxidative degradation of proteins, lipids, nucleic acids. Antioxidants may have a positive effect on t…
Phase 3 • Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Doulas and smart devices team up to tackle postpartum hypertension
Disease control OngoingThis is a single site, single-blinded parallel randomized control trial that investigates a multi-level intervention to improve postpartum blood pressure in women with hypertensive disorder pregnancy. The investigators will recruit women diagnosed with a hypertensive disorder of …
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Soy supplement shows promise for aging brains and arteries
Disease control OngoingThe ACE Trial, funded by the National Institute on Ageing/National Institutes of Health (NIH), is a multicenter clinical trial. The ACE Trial will determine if taking the dietary supplement Equol could slow the progression of stiffening of the arteries, small blood vessel disease…
Phase 2 • Sponsor: Akira Sekikawa • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Brain cancer breakthrough? CAR t cells injected directly into fluid around brain in new trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of intracerebroventricularly (ICV) administered CD19-chimeric antigen receptor (CAR) T cells in treating patients with central nervous system (CNS) lymphoma. CAR T cell therapy is a type of treatment in which a pati…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a 25-Year global study unlock the secrets of friedreich ataxia?
Knowledge-focused Recruiting nowThis project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Sponsor: Friedreich's Ataxia Research Alliance • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New lupus pill shows promise in Mid-Stage trial
Disease control CompletedA study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).
Phase 2 • Sponsor: Lakefront Biotherapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
ER study aims to stop patients being awake and paralyzed on ventilators
Knowledge-focused Recruiting nowThe investigators will screen all mechanically ventilated ED patients for study eligibility and will enroll all consecutive patients satisfying inclusion and exclusion criteria. The study design is a pragmatic, multicenter, stepped wedge cluster randomized trial, enrolling at fi…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare stomach cancer: chemo drug shows promise in early trial
Disease control Recruiting nowThe goal of this clinical trial is to investigate the efficacy and safety of temozolomide in SDH deficiency GIST patients.
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Laptop-based memory training may help reverse cognitive decline
Symptom relief Recruiting nowThe current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in individuals with Mild Cognitive Impairment (MCI). Impairment in higher level cognitive processing, such as new learning and memory, is one of the most com…
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New combo therapy aims to cut pain and opioid use in chronic sufferers
Symptom relief OngoingThis is a prospective, randomized clinical trial of 204 patients with opioid use disorder (OUD) and chronic pain (CP) to test the effectiveness of treatment as usual compared with Stepped Care for Patients to Optimize Whole Recovery (SC-POWR) to reduce pain interference (Aim 1) a…
Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC